Abstract:This study has hereby designed and synthesized MIL‐101(Cr)@CoOx nanoparticles to achieve ultrasound‐mediated synergistic tumor inhibition by combining CO gas therapy and chemodynamic therapy effectively. Carbon monoxide (CO) as an endogenous gaseous signaling molecule, is widely studied for its ability to inhibit cancer cell proliferation as gas therapy. However, the therapeutic efficiency of CO gas therapy is far from ideal due to the low availability of CO supply. Here, inspired by the band structure and Fenton‐related elements, MIL‐101(Cr)@CoOx nanoparticles are introduced for the first time to achieve ultrasound‐mediated synergistic therapy by combining CO gas therapy and chemodynamic therapy together effectively. MIL‐101(Cr)@CoOx can present substantial CO2 adsorption capacity for the BDC2− linkers and Co center, and enable to transformation of endogenous CO2 to CO efficiently under ultrasound irradiation due to the appropriate band structure and conduction band position. With the Co‐engaged Fenton‐like reaction, MIL‐101(Cr)@CoOx triggered the reactions to catalyze the over‐expressed intracellular H2O2 into cytotoxic hydroxyl radicals (·OH). The potential therapeutic outcome of chemodynamic therapy can be amplified by the ultrasonic cavitation‐induced conversion between Co3+ and Co2+ in vitro is demonstrated. The proliferation, ATP, and mitochondria functions of 4T1 mouse breast cancer cells are severely compromised by CO‐promoted ROS generation and the sono‐Fenton effect. Further, in vivo studies confirm that MIL‐101(Cr)@CoOx combined with ultrasound irradiation exhibits superior tumor suppression, and achieves the ultrasound‐mediated chemodynamic‐gas cancer therapy with higher precisions for personalized treatments. This new system offers a distinct concept for constructing smart ultrasound‐stimulus systems to realize synergetic cancer therapy.

Synthesis, structural characterization, molecular docking study, biological activity of carbon monoxide release molecules as potent antitumor agents

[Toxicology and Bioactivities of CO-releasing Molecules Based on Cobalt Complexes].

Synthesis and Biological Activities of Carbonyl Cobalt CORMs with Selectively Inhibiting Cyclooxygenase-2

Synthesis, toxicities and cell proliferation inhibition of CO-releasing molecules containing cobalt

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Syntheses and Anti-Cancer Activity of CO-releasing Molecules with Targeting Galactose Receptors

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-<em>N</em>-oxide Derivatives as Hypoxic Selective Anti-tumor Agents

Synthesis, Toxicity and Antitumor Activity of Cobalt Carbonyl Complexes Targeting Hepatocellular Carcinoma.

Synthesis, Structural Characterization and Preliminary Biological Studies of Several Heterocyclic Transition Metal Carbonyl Complexes

Synthesis, Docking and Biological Evaluation of Isoquinolonic Acid Derivatives

Synthesis of Dihydropyrazole Sulphonamide Derivatives That Act As Anti-Cancer Agents Through COX-2 Inhibition

Synthesis, Characterization and Biological Evaluation of a Cobalt(ii) Complex with 5‐chloro‐8‐hydroxyquinoline As Anticancer Agent

Synthesis, Biological Evaluation, and Molecular Docking Studies of Diacylhydrazine Derivatives Possessing 1,4-Benzodioxan Moiety As Potential Anticancer Agents

CoOx‐Caged Metal‐Organic Frameworks for Sonocatalyzing CO2 to Co for Ultrasound‐Assisted Chemodynamic‐Gas Cancer Therapy

Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity In Vitro

Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.

Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling

Discovery of Novel Aminophosphonate Derivatives Containing Pyrazole Moiety As Potential Selective COX-2 Inhibitors.

Ultrasound-Mediated Antitumor Therapy Via Targeted Acoustic Release Carrier of Carbon Monoxide (TARC-CO).

Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.

Toxicity, bio-distribution and metabolism of CO-releasing molecules based on cobalt.